Floatz logo

Marijuana

HIV Neuropathy

University of California, San DiegoPhase 2Dormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the HIV Neuropathy cohort.

Asset / SponsorPhaseRating
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Washington University School of Medicine
Phase 4BB
LIDOCAINE
Endo USA Inc., a Keenova Therapeutics Company
Phase 4BB
Neuron012703
Targeted Medical Pharma
Phase 2CCC

Same molecule, other indications

Marijuana is also rated in:

CannabisDormant
BB
Indicative ·
71 / 100
View asset →
Diabetic Peripheral Neuropathic PainDormant
B
Indicative ·
62 / 100
View asset →
Spinal Cord InjuryDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →